Petros Pharmaceuticals, Inc.
PTPI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6,070 | $7,322 | $8,931 | $3,710 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $416 |
| Inventory | $0 | $0 | $0 | $2,999 |
| Other Curr. Assets | $63 | $75 | $5,535 | $169 |
| Total Curr. Assets | $6,133 | $7,397 | $14,466 | $7,294 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $137 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $3,204 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $3,140 | $0 |
| Total NC Assets | $0 | $0 | $3,140 | $3,341 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $6,133 | $7,397 | $17,605 | $10,635 |
| Liabilities | – | – | – | – |
| Payables | $421 | $970 | $757 | $2,329 |
| Short-Term Debt | $0 | $0 | $0 | $7,311 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $1,716 | $0 | $0 |
| Other Curr. Liab. | $2,344 | $264 | $26,375 | $8,388 |
| Total Curr. Liab. | $2,765 | $2,950 | $27,132 | $18,028 |
| LT Debt | $0 | $0 | $0 | $75 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $58 | $0 |
| Total NC Liab. | $0 | $0 | $58 | $75 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $138 |
| Total Liabilities | $2,765 | $2,950 | $27,190 | $18,103 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $4 | $4 | $0 | $1 |
| Retained Earnings | -$110,958 | -$110,036 | -$115,468 | -$113,208 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $114,322 | $114,478 | $105,884 | $105,740 |
| Total Equity | $3,368 | $4,447 | -$9,584 | -$7,468 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $6,133 | $7,397 | $17,605 | $10,635 |
| Net Debt | -$6,070 | -$7,322 | -$8,931 | $3,676 |